BCWORLD PHARM. Co. Ltd
BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical company in South Korea. The company provides products in various therapeutic areas comprising musculoskeletal system, digestive system, circulatory machine, central nervous system, adrenocorticosteroids, narcotic analgesics, erectile dysfunction treatment, wellbeing injection, diuretic, antitussive expectorant, vaginitis treatment, anti-tuberc… Read more
BCWORLD PHARM. Co. Ltd (200780) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.020x
Based on the latest financial reports, BCWORLD PHARM. Co. Ltd (200780) has a cash flow conversion efficiency ratio of 0.020x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.43 Billion) by net assets (₩72.50 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BCWORLD PHARM. Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how BCWORLD PHARM. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
BCWORLD PHARM. Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BCWORLD PHARM. Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Prime Oil Chemical Service Corp
TW:2904
|
0.064x |
|
DIAGNOS Inc
OTCQB:DGNOF
|
0.539x |
|
Popular Vehicles and Services Limited
NSE:PVSL
|
-0.018x |
|
Samil Enterprise Co. Ltd
KQ:002290
|
-0.010x |
|
BACTIGUARD HLDG B
F:5JE
|
N/A |
|
LanzaTech Global Inc.
NASDAQ:LNZA
|
3.189x |
|
Lion Chemtech Co. Ltd
KQ:171120
|
0.068x |
|
Big Tree Cloud Holdings Limited Ordinary Shares
NASDAQ:DSY
|
0.318x |
Annual Cash Flow Conversion Efficiency for BCWORLD PHARM. Co. Ltd (2015–2024)
The table below shows the annual cash flow conversion efficiency of BCWORLD PHARM. Co. Ltd from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩76.67 Billion | ₩4.04 Billion | 0.053x | -60.64% |
| 2023-12-31 | ₩81.64 Billion | ₩10.94 Billion | 0.134x | +54.84% |
| 2022-12-31 | ₩79.55 Billion | ₩6.88 Billion | 0.087x | +1237.07% |
| 2021-12-31 | ₩81.46 Billion | ₩-619.83 Million | -0.008x | +85.94% |
| 2020-12-31 | ₩101.69 Billion | ₩-5.50 Billion | -0.054x | -143.45% |
| 2019-12-31 | ₩97.24 Billion | ₩12.11 Billion | 0.125x | +110.10% |
| 2018-12-31 | ₩90.09 Billion | ₩5.34 Billion | 0.059x | -39.05% |
| 2017-12-31 | ₩81.23 Billion | ₩7.90 Billion | 0.097x | +2848.61% |
| 2016-12-31 | ₩73.88 Billion | ₩243.66 Million | 0.003x | -97.47% |
| 2015-12-31 | ₩67.40 Billion | ₩8.78 Billion | 0.130x | -- |